Novavax Inc. has won a potentially lucrative fast-track designation from the U.S. Food and Drug Administration for one of its lead vaccine candidates to protect older patients against a respiratory virus known as RSV.
{iframe}http://www.bizjournals.com/washington/news/2016/05/26/novavax-gains-fda-fast-trackas-it-ramps-up-late.html?ana=e_du_pap&s=article_du&ed=2016-05-26&u=wjGEy67ABoSnsLErlc5ry0j5hx3&t=1464369002&j=73546802{/iframe}